Wei Cao

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

Zhenguang Wang, Na Li, Kaichao Feng et al. · Cellular and Molecular Immunology · 2021 · 239 citations · Full text

Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management

Shiqi Li, Xinxin Wang, Zhongtao Yuan et al. · Clinical Cancer Research · 2020 · 102 citations · Full text

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Junfang Yang, Jiaping He, Xian Zhang et al. · Blood Cancer Journal · 2022 · 90 citations · Full text

Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol

Xiao-yi Tang, Yao Sun, Ang Zhang et al. · BMJ Open · 2016 · 87 citations · Full text

Zeolite-based hemostat QuikClot releases calcium into blood and promotes blood coagulation in vitro

Jing Li, Wei Cao, Xiaoxing Lv et al. · Acta Pharmacologica Sinica · 2013 · 67 citations · Full text

Medicine, Physiology, Hematology +5